Adverse Events Associated with Sedatives, Analgesics, and Other Drugs That Provide Patient Comfort in the Intensive Care Unit

@article{Riker2005AdverseEA,
  title={Adverse Events Associated with Sedatives, Analgesics, and Other Drugs That Provide Patient Comfort in the Intensive Care Unit},
  author={Richard R. Riker and Gilles L Fraser},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2005},
  volume={25}
}
  • R. Riker, G. Fraser
  • Published 2005
  • Medicine
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Since the 2002 publication of multidisciplinary clinical practice guidelines for intensive care unit (ICU) sedation and analgesia, additional information regarding adverse drug events has been reported. Our understanding of the risks associated with these sedative and analgesic agents promises to improve outcomes by helping clinicians identify and respond to therapeutic misadventures sooner. This review focuses on many issues, including the potentially fatal consequences associated with the… Expand
Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit
TLDR
The most common and serious adverse drug events reported to occur with the use of sedatives, analgesics, and antipsychotics in the intensive care unit are reviewed; the pharmacokinetic, pharmacodynamic, and pharmacogenetic factors that can influence analgesic, sedative,and antipsychotic response and safety in the critically ill are highlighted; and strategies that can be used to minimize toxicity with these agents are identified. Expand
Analgesic and sedative agents used in the intensive care unit: A review
TLDR
Clinicians must be familiar with these classes of drugs to optimize pharmacotherapy and ensure as few side‐effects as possible for ICU patients. Expand
Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids.
TLDR
Clinicians should be familiar with the many pharmacokinetic, pharmacodynamic, and pharmacogenetic variables that can affect the safety and efficacy of sedatives and analgesics. Expand
Dexmedetomidine for sedation and perioperative management of critically ill patients
TLDR
This state of the art review examines the physiological properties and uses of alpha 2 agonists, with emphasis on dexmedetomidine, in the perioperative period and in the ICU. Expand
Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids.
TLDR
To optimize care, critical care clinicians should be familiar with the many pharmacokinetic, pharmacodynamic, and pharmacogenetic variables that can affect the safety and efficacy of these sedatives and analgesics. Expand
Clinical application : the use of dexmedetomidine in intensive care sedation.
TLDR
Dexmedetomidine has been demonstrated to be associated with both sedative and analgesic sparing effects, reduced delirium and agitation, minimal respiratory depression and predictable and desirable cardiovascular effects in the intensive care setting. Expand
Economic evaluation of sustained sedation/analgesia in the intensive care unit
TLDR
The cost parameters of intensive care unit sedation that are specific to the characteristics of commonly used sedatives and analgesics are reviewed, economic studies and cost models are evaluated, and practical recommendations for methods of cost containment are provided. Expand
Role of dexmedetomidine in adults in the intensive care unit: an update.
TLDR
In medical-surgical ICUs, dexmedetomidine may be a viable non-benzodiazepine option for patients with a need for light sedation and in cardiac surgery patients, DexmedetOMidine appears to offer no advantage over propofol as the initial sedative. Expand
Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine.
PURPOSE A review highlighting the application of sedatives and analgesics in the intensive care unit (ICU) setting, with a focus on the use of dexmedetomidine, is presented. SUMMARY Relevant andExpand
Editor’s Choice-The cardiovascular implications of sedatives in the cardiac intensive care unit
TLDR
The use of common sedatives available in the endotracheally intubated critically ill patient and their clinical and cardiovascular effects are described and judicious strategies minimizing sedative use are associated with decreases in morbidity and mortality. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 145 REFERENCES
Bradycardia Associated with Intravenous Methadone Administered for Sedation in a Patient with Acute Respiratory Distress Syndrome
TLDR
This case report demonstrates that caution is warranted when high dosages of methadone are administered because of its potential cardiac effects, and a 43–year‐old man with acute respiratory distress syndrome experienced bradycardia while receiving a continuous infusion of methamphetamineadone for sedation and mechanical ventilation management. Expand
Use of oral clonidine for sedation in ventilated paediatric intensive care patients
TLDR
Oral clonidine may be a safe and effective sedative in combination with morphine and lorazepam for young children with single-organ, respiratory failure and this agent may also exhibit opioid and benzodiazepine sparing effects in this patient group. Expand
Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]
TLDR
Analgesia-based sedation with remifentanil permitted significantly faster and more predictable awakening for neurological assessment and had a similar adverse event and haemodynamic profile to those of hypnotic-based regimens when used in critically ill neuro-intensive care unit patients for up to 5 days. Expand
Metabolic acidosis associated with propofol in the absence of other causative factors.
TLDR
A case of metabolic acidosis is reported, without ventilatory depression or hypoxia, in an otherwise healthy patient receiving propofol as the sole anesthetic agent during an ablation for atrial fibrillation. Expand
Intensive care sedation: a review of current British practice
TLDR
The use of neuromuscular blocking drugs and the indications for their use, the use of sedation policies and scoring systems, the influence of cost on drug choice, and theUse of propofol for sedation in paediatric patients are established. Expand
Indications for the Use of Propofol in Electroconvulsive Therapy
TLDR
Propofol may be a useful alternative to methohexital for the treatment of patients who have excessively long seizures and/or severe nausea and vomiting after ECT, more common among adolescents. Expand
Olanzapine vs haloperidol: treating delirium in a critical care setting
TLDR
Olanzapine is a safe alternative to haloperidol in delirious critical care patients, and may be of particular interest in patients in whom hal operidol is contraindicated. Expand
Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.
TLDR
Despite ventilation and intubation, patients sedated with dexmedetomidine could be easily roused to cooperate with procedures (e.g. physiotherapy, radiology) without showing irritation. Expand
Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
  • A. Multz
  • Medicine
  • Anesthesia and analgesia
  • 2003
TLDR
A patient in whom a continuous infusion of dexmedetomidine was safely used for a week to help in averting frank withdrawal symptoms from an opioid and benzodiazepines is reported on. Expand
Pharmacoeconomic assessment of propofol 2% used for prolonged sedation
TLDR
The new propofol 2% preparation is an effective sedative agent and is safe because of the low frequency of associated hypertriglyceridemia and the shorter weaning time associated with the use of propofl 2% as compared with midazolam compensates for its elevated cost. Expand
...
1
2
3
4
5
...